ARTICLE | Company News
Mylan Inc., Pfizer deal
January 6, 2014 8:00 AM UTC
On Dec. 18, 2013, Pfizer granted Mylan exclusive development and co-commercialization rights to an undisclosed novel long-acting muscarinic antagonist (LAMA) compound for undisclosed indications in th...